SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20043193
Source:
http://linkedlifedata.com/resource/pubmed/id/20043193
Search
Subject
(
70
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021102
,
umls-concept:C0025955
,
umls-concept:C0030685
,
umls-concept:C0033085
,
umls-concept:C0102137
,
umls-concept:C0391871
,
umls-concept:C0443252
,
umls-concept:C0597999
,
umls-concept:C0680255
,
umls-concept:C0871261
,
umls-concept:C1283071
,
umls-concept:C1515655
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C1963578
,
umls-concept:C1998793
,
umls-concept:C2911692
pubmed:issue
2
pubmed:dateCreated
2010-1-28
pubmed:abstractText
To assess whether prevention of unexpected in vivo adverse inflammatory and immune responses to biohybrid organ grafts for the treatment of Type I Diabetes Mellitus (T1DM) is possible by superoxide dismutase and ketoprofen controlled release.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8406521
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alginates
,
http://linkedlifedata.com/resource/pubmed/chemical/Capsules
,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucuronic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/Hexuronic Acids
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/alginic acid
,
http://linkedlifedata.com/resource/pubmed/chemical/polyornithine
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1573-904X
pubmed:author
pubmed-author:BastaGiuseppeG
,
pubmed-author:BecchettiEnnioE
,
pubmed-author:BlasiPaoloP
,
pubmed-author:CalafioreRiccardoR
,
pubmed-author:CalvittiMarioM
,
pubmed-author:FallarinoFrancescaF
,
pubmed-author:GiovagnoliStefanoS
,
pubmed-author:LucaGiovanniG
,
pubmed-author:MancusoFrancescaF
,
pubmed-author:RicciMaurizioM
,
pubmed-author:RossiCarloC
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
285-95
pubmed:meshHeading
pubmed-meshheading:20043193-Absorbable Implants
,
pubmed-meshheading:20043193-Alginates
,
pubmed-meshheading:20043193-Animals
,
pubmed-meshheading:20043193-Biological Availability
,
pubmed-meshheading:20043193-Capsules
,
pubmed-meshheading:20043193-Delayed-Action Preparations
,
pubmed-meshheading:20043193-Diabetes Mellitus, Type 1
,
pubmed-meshheading:20043193-Glucuronic Acid
,
pubmed-meshheading:20043193-Hexuronic Acids
,
pubmed-meshheading:20043193-Mice
,
pubmed-meshheading:20043193-Microspheres
,
pubmed-meshheading:20043193-Particle Size
,
pubmed-meshheading:20043193-Peptides
pubmed:year
2010
pubmed:articleTitle
Bioactive long-term release from biodegradable microspheres preserves implanted ALG-PLO-ALG microcapsules from in vivo response to purified alginate.
pubmed:affiliation
Dipartimento di Chimica e Tecnologia del Farmaco, Faculty of Pharmacy, University of Perugia, Via del Liceo 1, Perugia, 06123, Italy. eureka@unipg.it
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't